LIVERPOOL SCHOOL OF TROPICAL MEDICINE
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- -
- Established
- 1898-01-01
- Employees
- 650
- Market Cap
- -
- Website
- https://www.lstmed.ac.uk/
Evaluating ATSBs for Malaria Reduction in Kenya
Not Applicable
Completed
- Conditions
- Malaria
- First Posted Date
- 2022-02-02
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 2962
- Registration Number
- NCT05219565
- Locations
- 🇰🇪
Naya Health Centre, Siaya, Siaya County, Kenya
🇰🇪Benga Dispensary, Siaya, Siaya County, Kenya
🇰🇪Boro Dispensary, Siaya, Siaya County, Kenya
Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug
Phase 1
Terminated
- Conditions
- OnchocerciasisFilariasis, Lymphatic
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-10-20
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT05084560
- Locations
- 🇬🇧
Liverpool University Hospitals NHS Foundation Trust, Liverpool, Merseyside, United Kingdom
Evaluation of Safety and Dosing of a Vitamin C Bundle for Sepsis Treatment in Africa
- First Posted Date
- 2021-08-10
- Last Posted Date
- 2021-09-08
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT04999137
- Locations
- 🇺🇬
Infectious Diseases Institute, Makerere University, Kampala, Uganda
🇺🇬Kiruddu National Referral Hospital, Kampala, Uganda
PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)
Phase 4
Recruiting
- Conditions
- Streptococcus Pneumonia
- First Posted Date
- 2021-07-23
- Last Posted Date
- 2023-01-05
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 516
- Registration Number
- NCT04974294
- Locations
- 🇬🇧
Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia
Phase 3
Completed
- Conditions
- Sickle Cell Anemia in ChildrenMalaria
- Interventions
- First Posted Date
- 2021-04-14
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 723
- Registration Number
- NCT04844099
- Locations
- 🇲🇼
Queen Elizabeth Hospital, Blantyre, Malawi
🇺🇬Jinja Regional Referral hospital, Jinja, Uganda
🇺🇬Kitgum General Hospital, Kitgum, Uganda
MiMBa Pregnancy Registry
Recruiting
- Conditions
- Malaria in PregnancyPregnancy RelatedCongenital Anomaly
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 15000
- Registration Number
- NCT04825782
- Locations
- 🇰🇪
Kenya Medical Research Institute, Kisumu, Kenya
Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso
Phase 3
Completed
- Conditions
- MalariaCovid-19
- Interventions
- Drug: Artemether-lumefantrine (AL)Drug: Pyronaridine-artesunate (PA)
- First Posted Date
- 2021-01-05
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 143
- Registration Number
- NCT04695197
- Locations
- 🇧🇫
Ouagadougou Hospitals, Ouagadougou, Burkina Faso
🇰🇪Kisumu County Referral Hospital, Kisumu, Kenya
Male Partner-assisted Contact Tracing for HIV and Tuberculosis in Malawi
Phase 2
Terminated
- Conditions
- Tuberculosis
- First Posted Date
- 2020-02-26
- Last Posted Date
- 2021-02-25
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT04285905
- Locations
- 🇲🇼
Bangwe Health Centre, Blantyre, Southern Region, Malawi
Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya
Phase 4
Completed
- Conditions
- Malaria in PregnancyAdherence, Treatment
- Interventions
- Drug: Monthly intermittent preventive treatment with dihydroartemisnin-piperaquineDrug: Monthly intermittent preventive treatment with dihydroartemisnin-piperaquine with targeted information transfer
- First Posted Date
- 2019-11-12
- Last Posted Date
- 2021-04-15
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 1600
- Registration Number
- NCT04160026
- Locations
- 🇰🇪
Kenya Medical Research Institute, Kisumu, Kenya
Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)
Phase 3
Completed
- Conditions
- Pregnancy; HIV; Malaria
- Interventions
- Drug: Intermittent Preventive Therapy with Dihydroartemisinin-Piperaquine
- First Posted Date
- 2019-11-12
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 898
- Registration Number
- NCT04158713
- Locations
- 🇰🇪
Kenya Medical Research Institute, Kisumu, Kenya